Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using shock wave therapy to treat lower limb lymphedema

Official title: Lower Limb Lymphedema Treatment by Extracorporeal Shock Wave Therapy: Clinical Trial

Run by Parc de Salut Mar · NCT06454734 · Data updated 2026-11-12

This study is testing if adding shock wave therapy to regular treatments can help people with lower limb lymphedema feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorParc de Salut Mar
Academic / other
Locations1 site (Barcelona)
StatusRecruiting
StartedMay 28, 2024
Main results expectedJuly 2026
Study endsDecember 2026
Registry record updatedJuly 31, 2025
Trial IDNCT06454734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with moderate to severe lower limb lymphedema lasting at least 6 months.

Probably not a fit

Patients with coagulation disorders, recent deep vein thrombosis, or those unable to walk independently may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of shock wave therapy combined with complex decongestive therapy for patients suffering from lower limb lymphedema. It involves a double-blind, randomized design with two groups: one receiving the active shock wave therapy and the other receiving a placebo. Both groups will undergo standard treatments including manual lymphatic drainage and compression, with a total of 10 sessions over 5 weeks. The study aims to assess the impact of shock wave therapy on lymphedema symptoms and overall patient outcomes.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the management of lower limb lymphedema, enhancing patients' quality of life.

How similar studies have gone: While the use of shock wave therapy is a novel approach in this context, similar studies have shown promise in other conditions, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* Patients with lower limb lymphedema
* Lymphedema of at least 6 months of evolution
* The lymphedema must affect at least the knee to the foot
* Moderate or severe lymphedema (grades 2 or 3)
* Sign the informed consent

Exclusion criteria

* Under 18 years of age
* Coagulation disorders (hemophilia, treatment with acenocoumarol, etc.)
* Current or previous deep vein thrombosis of the lower extremity
* Pregnancy
* Electronic implantable medical devices as pacemaker implants, medication pumps, etc
* Having received treatment with complex decongestive therapy or shock waves during the last 6 months
* Treatment with corticosteroids or radiotherapy in the area to be treated in the last 6 weeks
* Active oncological disease in the area to be treated
* Active infectious-inflammatory process in the area to be treated
* Cognitive or sensory deficits that prevent collaboration
* Inability to walk independently or inability to attend therapy

Where it's running

  • Hospital del Mar
    Barcelona, Spain
    Recruiting

Study contacts

  • Principal investigator: Roser Belmonte, MD, PhD — Hospital del Mar
  • Study coordinator: Roser Belmonte, MD, PhD
  • Email: rbelmonte@psmar.cat
  • Phone: +34 933674214

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.